Joon Kwang Lee

Title: Joon Kwang Lee: Innovator in Anti-Angiogenic Compounds

Introduction

Joon Kwang Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit angiogenesis. His work is crucial for advancing treatments for diseases associated with abnormal vascular growth.

Latest Patents

Joon Kwang Lee holds a patent for a compound having angiogenesis inhibitory activity. The patent, titled "Compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same," discloses an anti-angiogenic compound represented by Chemical Formula I. This compound, or its pharmaceutically acceptable salt, is designed to suppress angiogenesis effectively. It is applicable in the prevention and treatment of diseases caused by aberrant activity of vascular endothelial growth factor, making it a valuable anti-angiogenic agent.

Career Highlights

Lee is associated with Boryung Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that can significantly impact patient care and health outcomes.

Collaborations

Some of his notable coworkers include Ji Han Kim and Je Hak Kim, who contribute to the collaborative efforts in research and development at Boryung Pharmaceutical Co., Ltd.

Conclusion

Joon Kwang Lee's contributions to the field of anti-angiogenic compounds highlight his role as an important inventor in the pharmaceutical industry. His innovative work has the potential to lead to significant advancements in medical treatments.